Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries
March 27 (Reuters) - Medtronic MDT.N said on Friday the U.S. Food and Drug Administration has cleared its surgical system for use in cranial and ear, nose and throat procedures, expanding the platform beyond the spine indication it received earlier this year. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Shreya Biswas) ((siddhi.mahatole@thomsonreuters.com;))
Recent news on Medtronic
See all newsStreet View: Medtronic moves from 'show me' story to 'trust the setup' story
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
Medtronic climbs after Q4 results beat estimates